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a b s t r a c t
Gene and cell-based therapies comprise innovative aspects of regenerative medicine. Even though stem
cells represent a highly potential therapeutic strategy, their wide-spread exploitation is marred by ethical
concerns, potential for malignant transformation and a plethora of other technical issues, largely
restricting their use to experimental studies. Utilizing genetically modiﬁed human umbilical cord blood
mono-nuclear cells (hUCB-MCs), this communication reports enhanced differentiation of transplants in a
mouse model of amyotrophic lateral sclerosis (ALS). Over-expressing Oct4 and Sox2 induced production
of neural marker PGP9.5, as well as transformation of hUCB-MCs into micro-glial and endothelial lines in
ALS spinal cords. In addition to producing new nerve cells, providing degenerated areas with trophic
factors and neo-vascularisation might prevent and even reverse progressive loss of moto-neurons and
skeletal muscle paralysis.
 2014 Elsevier Inc. All rights reserved.
1. Introduction
Regeneration is a fundamental feature of a living organism,
responsible for the restoration of tissues during vital activity as
well as after injures induced by endogenous and exogenous factors.
Stimulation of the regeneration is inherently related to the life
quality in patients with degenerative diseases, ischemic damages
and traumatic injuries. Development of new technologies, such
as gene and cell therapies, gave rise to the new ﬁndings, demon-
strating the capability of these methods to stimulate the process
of regeneration. Furthermore, preclinical trials and clinical applica-
tion of the high technologies resulted from new discoveries in
physics and chemistry have a great potential for the development
of the regenerative medicine.
Organ allografting (for instance, heart, kidney or liver transplan-
tation) is now accepted as a routine method in the clinical practice,
while cell transplantation (bone marrow transplantation, periphe-
ral and umbilical cord blood mononuclear cells transplantation) is
mainly restricted to the therapy of blood disorders, for example,
anaemia, hemoblastosis and cancer chemotherapy. Extensive
research in the ﬁeld of cellular therapy revealed its high efﬁciency
in the stimulation of regeneration in the affected organs. However,
advances in the ﬁeld of stem cell therapy are mainly in the exper-
imental studies because of ethical issues (the use of embryo and
fetus derived cells), a risk of malignant transformation of trans-
planted stem cells, recipient infection with unknown pathogens
from human donors and animal derived products used in cell cul-
ture, immune response to allogeneic cells. Thus, the cells subjected
to the transplantation must have predictable and reproducible
characteristics, namely – retain their viability; actively proliferate
to produce a sufﬁcient number of cells for the regeneration of
injured tissues; be capable to integrate with host cells;
differentiate into required cell types; restore a tissue structure
and form a guide pathway for the regenerating axons; participate
in re-myelination; produce the trophic and neuroprotective
factors; stimulate neurite outgrowth and re-establishment of an
intracellular contacts.
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